CRISPR Therapeutics AG Statistics
Total Valuation
CRSP has a market cap or net worth of $4.27 billion. The enterprise value is $2.60 billion.
Important Dates
The next estimated earnings date is Monday, November 4, 2024, after market close.
Earnings Date | Nov 4, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CRSP has 88.52 million shares outstanding. The number of shares has increased by 3.72% in one year.
Shares Outstanding | 88.52M |
Shares Change (YoY) | +3.72% |
Shares Change (QoQ) | +3.82% |
Owned by Insiders (%) | 0.45% |
Owned by Institutions (%) | 65.68% |
Float | 87.07M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 19.93 |
Forward PS | 30.92 |
PB Ratio | 2.12 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 12.85 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.73, with a Debt / Equity ratio of 0.12.
Current Ratio | 15.73 |
Quick Ratio | 15.66 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -14.00% and return on invested capital (ROIC) is -10.37%.
Return on Equity (ROE) | -14.00% |
Return on Assets (ROA) | -9.77% |
Return on Capital (ROIC) | -10.37% |
Revenue Per Employee | $496,872 |
Profits Per Employee | -$653,081 |
Employee Count | 407 |
Asset Turnover | 0.09 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CRSP has paid $2.66 million in taxes.
Income Tax | 2.66M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.37% in the last 52 weeks. The beta is 1.67, so CRSP's price volatility has been higher than the market average.
Beta (5Y) | 1.67 |
52-Week Price Change | +4.37% |
50-Day Moving Average | 50.82 |
200-Day Moving Average | 60.77 |
Relative Strength Index (RSI) | 54.42 |
Average Volume (20 Days) | 975,376 |
Short Selling Information
The latest short interest is 17.44 million, so 19.70% of the outstanding shares have been sold short.
Short Interest | 17.44M |
Short Previous Month | 17.17M |
Short % of Shares Out | 19.70% |
Short % of Float | 20.03% |
Short Ratio (days to cover) | 14.44 |
Income Statement
In the last 12 months, CRSP had revenue of $202.23 million and -$265.80 million in losses. Loss per share was -$3.27.
Revenue | 202.23M |
Gross Profit | -282.47M |
Operating Income | -354.68M |
Pretax Income | -263.15M |
Net Income | -265.80M |
EBITDA | -335.17M |
EBIT | -354.68M |
Loss Per Share | -$3.27 |
Full Income Statement Balance Sheet
The company has $2.00 billion in cash and $231.30 million in debt, giving a net cash position of $1.78 billion or $20.13 per share.
Cash & Cash Equivalents | 2.00B |
Total Debt | 231.30M |
Net Cash | 1.78B |
Net Cash Per Share | $20.13 |
Equity (Book Value) | 1.98B |
Book Value Per Share | 23.29 |
Working Capital | 1.88B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$121.76 million and capital expenditures -$4.28 million, giving a free cash flow of -$126.04 million.
Operating Cash Flow | -121.76M |
Capital Expenditures | -4.28M |
Free Cash Flow | -126.04M |
FCF Per Share | -$1.42 |
Full Cash Flow Statement Margins
Gross margin is -139.68%, with operating and profit margins of -175.39% and -131.44%.
Gross Margin | -139.68% |
Operating Margin | -175.39% |
Pretax Margin | -130.13% |
Profit Margin | -131.44% |
EBITDA Margin | -165.74% |
EBIT Margin | -175.39% |
FCF Margin | -62.33% |
Dividends & Yields
CRSP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.72% |
Shareholder Yield | -3.72% |
Earnings Yield | -6.07% |
FCF Yield | -2.88% |
Dividend Details Analyst Forecast
The average price target for CRSP is $74.38, which is 54.32% higher than the current price. The consensus rating is "Buy".
Price Target | $74.38 |
Price Target Difference | 54.32% |
Analyst Consensus | Buy |
Analyst Count | 19 |
Revenue Growth Forecast (5Y) | 42.09% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CRSP has an Altman Z-Score of 7.82 and a Piotroski F-Score of 4.
Altman Z-Score | 7.82 |
Piotroski F-Score | 4 |